Zoetis ZTS
NYSE ZTS
$73.03 -0.28 (-0.38%)
As of: Sep 10, 2026 · 1:46 PM EDT

Zoetis (ZTS) Construction in Progress (2012 - 2025)

Zoetis' (ZTS) quarterly Construction in Progress came in at $1.3 billion in Q4 2025, down 4.29% year-over-year from $1.4 billion in Q4 2024, and down 4.29% quarter-over-quarter from $1.4 billion in Q4 2024.

Analysis

Zoetis (ZTS) Construction in Progress (2012 - 2025) Analysis & Trends

Zoetis (ZTS) has reported Construction in Progress for 14 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Construction in Progress fell 4.29% year-over-year to $1.3 billion in Q4 2025; TTM through Dec 2025 was $1.3 billion, a 4.29% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 4.29% from the prior year.
  • Construction in Progress was $1.3 billion for Q4 2025 at Zoetis, down from $1.4 billion in the prior quarter.
  • Over five years, Construction in Progress peaked at $1.4 billion in Q4 2024 and troughed at $742.0 million in Q4 2021.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Construction in Progress.
  • Across the five-year window, Construction in Progress soared 33.29% in 2023 and declined 4.29% in 2025, its largest moves.
  • Over 5 years, Construction in Progress stood at $742.0 million in 2021, then rose by 9.7% to $814.0 million in 2022, then soared by 33.29% to $1.1 billion in 2023, then advanced by 24.7% to $1.4 billion in 2024, then retreated by 4.29% to $1.3 billion in 2025.
  • The last three Construction in Progress figures came in at $1.3 billion (Q4 2025), $1.4 billion (Q4 2024), and $1.1 billion (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Idexx Laboratories 40.03 Bn 39.83 Bn 779.09 Mn -
2 Zoetis 30.51 Bn 28.83 Bn 1.05 Bn -
3 Elanco Animal Health 11.50 Bn 10.97 Bn 798.00 Mn -
4 Phibro Animal Health 1.48 Bn 1.40 Bn 134.40 Mn -
5 Immucell 89.38 Mn 80.52 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 75.81 Mn 68.71 Mn - 86,005.49
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Bn
Dec 31, 2024 1.35 Bn
Dec 31, 2023 1.09 Bn
Dec 31, 2022 814.00 Mn
Dec 31, 2021 742.00 Mn
Dec 31, 2020 673.00 Mn
Dec 31, 2019 553.00 Mn
Dec 31, 2018 454.00 Mn
Dec 31, 2017 254.00 Mn
Dec 31, 2016 212.00 Mn
Dec 31, 2015 185.00 Mn
Dec 31, 2014 167.00 Mn
Dec 31, 2013 199.00 Mn
Dec 31, 2012 159.00 Mn